PACLX
Price
$34.03
Change
-$4.12 (-10.80%)
Updated
Dec 18 closing price
RPBAX
Price
$26.25
Change
-$2.08 (-7.34%)
Updated
Dec 18 closing price
Ad is loading...

PACLX vs RPBAX

Header iconPACLX vs RPBAX Comparison
Open Charts PACLX vs RPBAXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$34.03
Change-$4.12 (-10.80%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Balanced
Price$26.25
Change-$2.08 (-7.34%)
VolumeN/A
CapitalizationN/A
PACLX vs RPBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PACLX vs. RPBAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and RPBAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 66.1B vs. RPBAX (4.76B). RPBAX pays higher dividends than PACLX: RPBAX (1.95) vs PACLX (1.77). PACLX was incepted earlier than RPBAX: PACLX (20 years) vs RPBAX (85 years). PACLX is a more actively managed with annual turnover of: 65.10 vs. RPBAX (40.90). PACLX (2500) and RPBAX (2500) have matching initial minimum investment requirements. RPBAX (13.35) and PACLX (13.32) have marching annual gain over last year. PACLX return over 5 years is better than : 29.42 vs. RPBAX (22.91).
PACLXRPBAXPACLX / RPBAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years85 years-
Gain YTD14.25614.039102%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets66.1B4.76B1,390%
Annual Yield % from dividends1.771.9591%
Returns for 1 year13.3213.35100%
Returns for 3 years9.688.18118%
Returns for 5 years29.4222.91128%
Returns for 10 years62.5643.94142%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI13.010.11
+0.85%
Greenwich LifeSciences
TXT80.07-1.27
-1.56%
Textron
FBP19.45-0.61
-3.04%
First BanCorp
IMNM12.02-0.42
-3.38%
Immunome
CTHR1.52-0.14
-8.43%
Charles & Colvard Ltd.